Page results
-
Dr Alegre Abarrategui is a consultant in diagnostic neuropathology offering diagnostic services across neuropathology subspecialties, especially surgical neuropathology, neuromuscular neuropathology, and neurodegeneration.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
UCLH is pleased to present the first strategic workforce plan for University College London Hospitals NHS Foundation Trust (UCLH). Providing top quality care to all our patients is at the core of everything we do, and our diverse workforce is key to delivery.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
The Elizabeth Garrett Anderson maternity service at UCLH has been rated ‘Good’ following an inspection by the Care Quality Commission (CQC) in June 2023.
-
Testing for NHS staff, provided by the Francis Crick Institute and UCLH NHS Foundation Trust, detected COVID-19 infections that would have otherwise been missed.
-
A breathing pattern disorder is an alteration/abnormal pattern of breathing.
-
Temporary change to HIV confirmation pathway due to Bio-Rad kit supply issues
-
A number of tests are carried out by the routine haemostasis/haematology laboratories. These include full blood count, ESR, sickle cell and glandular fever screening, malaria antigen testing, blood films and acanthocytes, coagulation screens (INR/heparin monitoring), fibrinogen and D-dimers (DIC screening).
-
A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCLH, UCL and the Francis Crick Institute.
File results
-
FOI/2024/0482 - Medical device/ enterprise application Integration/ data warehouse systems
-
FOI/2024/0368 - Treatment in renal cell carcinoma
-
FOI/2023/0418 - GIDS service patient referrals and treatment
-
FOI/2022/0655 - GIDS patients who have been prescribed GnRH analogues
-
FOI/2024/0480 - Freedom of Information (FOI) requests 2020/21-2023/24
-
FOI/2024/0479 - Applications or systems deployed on Microsoft Azure Cloud
-
FOI/2024/0478 - Elective operations cancelled for non-clinical reasons 2021/22-2023/24
-
FOI/2024/0473 - Elective operations cancelled for non-clinical reasons 2023/24
-
FOI/2024/0254 - Urothelial and endometrial cancer treatments
-
FOI/2024/0246 - Gastric and gastro-oesophageal/ non-small cell lung/ renal cell carcinoma cancer treatments